Innovate GAAP EPS of -$0.58, revenue of $382.7M

Seeking Alpha - Thu, 03/26/2026 - 15:24

Madrigal Pharmaceuticals gains amid renewed takeover speculation

Seeking Alpha - Thu, 03/26/2026 - 15:24

Vivani Medical GAAP EPS of -$0.43 misses by $0.01

Seeking Alpha - Thu, 03/26/2026 - 15:24

CapsoVision, Inc. reports Q4 results

Seeking Alpha - Thu, 03/26/2026 - 15:23

Software is seeing a disconnect in sentiment and reality – Vista Equity Partners

Seeking Alpha - Thu, 03/26/2026 - 15:23

Rani Therapeutics GAAP EPS of -$0.07 in-line, revenue of $1.46M misses by $3.54M

Seeking Alpha - Thu, 03/26/2026 - 15:23

P3 Health Partners GAAP EPS of -$23.02 misses by $13.56, revenue of $384.8M beats by $27.15M

Seeking Alpha - Thu, 03/26/2026 - 15:21

Fed should stay on sidelines amid market uncertainty - Goldman's Robert Kaplan

Seeking Alpha - Thu, 03/26/2026 - 15:20

Laird Superfood GAAP EPS of -$0.16 misses by $0.09, revenue of $13.35M beats by $0.21M

Seeking Alpha - Thu, 03/26/2026 - 15:18

IRIDEX GAAP EPS of -$0.01 beats by $0.01, revenue of $14.7M misses by $0.04M

Seeking Alpha - Thu, 03/26/2026 - 15:18

BIZD Vs. PBDC: Why I'm Downgrading To 'Sell' As The Yield Trap Closes

Seeking Alpha - Thu, 03/26/2026 - 15:18

XMHQ Struggles To Earn Market-Beating Returns, Consider Alternatives

Seeking Alpha - Thu, 03/26/2026 - 15:18

Oxford Industries GAAP EPS of -$0.48 misses by $0.52, revenue of $374.5M beats by $2.66M

Seeking Alpha - Thu, 03/26/2026 - 15:16

The U.S. Labor Market Confounds With Its Countercurrents; It May Be The New Normal Labor Market

Seeking Alpha - Thu, 03/26/2026 - 15:15

Datacentrex announces proposed public offering

Seeking Alpha - Thu, 03/26/2026 - 15:14

Newsmax Inc. reports Q4 results

Seeking Alpha - Thu, 03/26/2026 - 15:14

Zenas BioPharma announces concurrent public offerings of convertible senior notes and common stock

Seeking Alpha - Thu, 03/26/2026 - 15:13

Ferrari resumes Middle East shipments

Seeking Alpha - Thu, 03/26/2026 - 15:13

Beyond Air CEO Steve Lisi resigns, Robert Goodman appointed successor

Seeking Alpha - Thu, 03/26/2026 - 15:10

Spero Therapeutics Non-GAAP EPS of $0.53, revenue of $41.3M

Seeking Alpha - Thu, 03/26/2026 - 15:09

Pages